Home › Myeloproliferative Neoplasms › Rhode Island › Providence
Myeloproliferative Neoplasms clinical trials in Providence, RI
4 studies for Myeloproliferative Neoplasms are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Rhode Island Hospital, Providence
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Rhode Island Hospital, Providence
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Rhode Island Hospital, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Providence
Myeloproliferative Neoplasms trials in other cities
- Houston, TX16 studies
- New York City, NY15 studies
- Boston, MA14 studies
- Miami, FL10 studies
- Milwaukee, WI10 studies
- Baldwin Park, CA9 studies
- Seattle, WA9 studies
- Durham, NC9 studies
- Chicago, IL9 studies
- St. Louis, MO8 studies
- Cleveland, OH8 studies
- Birmingham, AL8 studies
Other studies in Providence
- Endometrial Cancer15 studies
- Ovarian Cancer15 studies
- Obesity14 studies
- Cancer (all types)13 studies
- Crohn's Disease12 studies
- Non-Small Cell Lung Cancer12 studies
- Breast Cancer11 studies
- Ulcerative Colitis11 studies
- Acute Myeloid Leukemia10 studies
- Overweight9 studies
- Metastatic Cancer9 studies
- Alcohol Use Disorder (AUD)8 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.